Synthesis of Self-Amplifying Nucleic Acid Constructs

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation; offers are being requested, and a separate written solicitation will not be issued. Solicitation number 1232SA25Q044 is issued as a Request for Quotation (RFQ) for a service to generate five lipid nanoparticle encapsulated self-amplifying nucleic acid based on the genetic components of the alphavirus Venezuelan equine encephalitis virus (VEEV).

This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The applicable North American Industry Classification Standard Code is 541380. The small business size standard is $19.0M This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency. See “Attachment 1 - Solicitation Terms and Conditions” for applicable clauses, instructions, and evaluation criteria.